Astrazeneca ADR Aktie
72,50 €
Deine Einschätzung
Astrazeneca ADR Aktie
Was spricht für und gegen Astrazeneca ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Astrazeneca ADR im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | 0,00 % | 2,11 % | 9,02 % | 5,07 % | 17,89 % | 53,60 % | - |
GSK plc ADR | 0,00 % | 0,97 % | 8,29 % | 26,67 % | 24,40 % | 4,50 % | -6,64 % |
Bayer AG ADR | 0,74 % | -4,26 % | 2,27 % | -49,63 % | -21,51 % | -50,73 % | -50,37 % |
Roche Holding AG ADR | -1,32 % | -2,63 % | 0,28 % | -20,44 % | -9,52 % | -17,41 % | - |
Kommentare
https://www.nasdaq.com/articles/is-it-too-late-to-buy-the-most-promising-pipeline-in-the-pharma-industry-2021-05-28
News
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AstraZeneca Plc (NASDAQ: AZN)Q1 2024 Earnings CallApr 25, 2024, 6:45 a.m. ET
Operator
Source Fool.com
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
Weight-loss drugs are hot. Just look at the recent performances of Eli Lilly (NYSE: LLY), which won U.S. approval in November for Zepbound, and Novo Nordisk (NYSE: NVO), which markets Ozempic and